Brief: Propanc Biopharma prepares orphan drug application for ovarian cancer drug
02/08/2017 13:30
Aug 2 (Reuters) - Propanc Biopharma Inc PPCB.PK
* Company prepares orphan drug designation application to
FDA for treatment of ovarian cancer
Source text for Eikon: ID:nMKWR7Qjya
Further company coverage: PPCB.PK
((bangalore.newsroom@thomsonreuters.com;))